Co-Authors
This is a "connection" page, showing publications co-authored by Chloé Dimeglio and Jean-Michel Mansuy.
Connection Strength
1.947
-
Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2. Viruses. 2021 05 12; 13(5).
Score: 0.236
-
COVID-19 pandemic period, where are the seasonal viruses? J Med Virol. 2021 Jul; 93(7):4097-4098.
Score: 0.235
-
Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France. Rev Med Virol. 2021 09; 31(5):1-8.
Score: 0.234
-
Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France. J Infect. 2021 May; 82(5):186-230.
Score: 0.232
-
Quantifying the impact of public health protection measures on the spread of SARS-CoV-2. J Infect. 2021 03; 82(3):414-451.
Score: 0.228
-
Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021 01; 82(1):e29-e32.
Score: 0.226
-
Children are protected against SARS-CoV-2 infection. J Clin Virol. 2020 07; 128:104451.
Score: 0.221
-
The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France. J Infect. 2020 Aug; 81(2):318-356.
Score: 0.220
-
Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study. Diagn Microbiol Infect Dis. 2021 Nov; 101(3):115478.
Score: 0.060
-
Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers. J Clin Virol. 2020 09; 130:104580.
Score: 0.056